TrialViruses2025

Adrenomedullin Therapy for Moderate-to-Severe COVID-19 Pneumonia: Double-Blind Placebo-Controlled Phase 2a Trial.

Toshihiro Kita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.